New cancer clinical trial: A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Published on: June 29, 2018 at 12:00PM
Condition:   Thyroid Neoplasms
Intervention:   Drug: Lenvatinib
Sponsor:   Eisai Inc.
Recruiting
https://ift.tt/2IERPDr